{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:42:44Z","timestamp":1792896164108,"version":"4.5.0"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inappropriate levels of hyperactivity, impulsivity, and inattention characterize attention deficit hyperactivity disorder, a common childhood-onset neuropsychiatric disorder. The cognitive function and learning ability of children with attention deficit hyperactivity disorder are affected, and these symptoms may persist to adulthood if they are not treated. The diagnosis of attention deficit hyperactivity disorder is only based on symptoms and objective tests for attention deficit hyperactivity disorder are missing. Treatments for attention deficit hyperactivity disorder in children include medications, behavior therapy, counseling, and education services which can relieve many of the symptoms of attention deficit hyperactivity disorder but cannot cure it. There is a need for a molecular biomarker to distinguish attention deficit hyperactivity disorder from healthy subjects and other neurological conditions, which would allow for an earlier and more accurate diagnosis and appropriate treatment to be initiated. Abnormal expression of microRNAs is connected to brain development and disease and could provide novel biomarkers for the diagnosis and prognosis of attention deficit hyperactivity disorder. The recent studies reviewed had performed microRNA profiling in whole blood, white blood cells, blood plasma, and blood serum of children with attention deficit hyperactivity disorder. A large number of microRNAs were dysregulated when compared to healthy controls and with some overlap between individual studies. From the studies that had included a validation set of patients and controls, potential candidate biomarkers for attention deficit hyperactivity disorder in children could be miR-140-3p, let-7g-5p, -30e-5p, -223-3p, -142-5p, -486-5p, -151a-3p, -151a-5p, and -126-5p in total white blood cells, and miR-4516, -6090, -4763-3p, -4281, -4466, -101-3p, -130a-3p, -138-5p, -195-5p, and -106b-5p in blood serum. Further studies are warranted with children and adults with attention deficit hyperactivity disorder, and consideration should be given to utilizing rat models of attention deficit hyperactivity disorder. Animal studies could be used to confirm microRNA findings in human patients and to test the effects of targeting specific microRNAs on disease progression and behavior.<\/jats:p>","DOI":"10.4103\/1673-5374.380880","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T13:07:04Z","timestamp":1691759224000},"page":"557-562","source":"Crossref","is-referenced-by-count":12,"title":["MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder"],"prefix":"10.4103","volume":"19","author":[{"given":"Bridget","family":"Martinez","sequence":"first","affiliation":[{"name":"Department of Pharmacology, University of Nevada-Reno, Reno, USA"},{"name":"Department of Medicine, University of Nevada-Reno, Reno, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5468-1989","authenticated-orcid":false,"given":"Philip V.","family":"Peplow","sequence":"additional","affiliation":[{"name":"Department of Anatomy, University of Otago, Dunedin, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"R1-20230927","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbrc.2009.11.005","article-title":"Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction","volume":"39","author":"Ai","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"11 Suppl 1","key":"R2-20230927","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.3949\/ccjm.82.s1.01","article-title":"ADHD and behavioral disorders:assessment, management, and an update from DSM-5","volume":"82","author":"Austerman","year":"2015","journal-title":"Cleveland Clinic J Med"},{"key":"R3-20230927","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jpsychires.2019.05.021","article-title":"Altered microRNA 5692b and microRNA let-7d expression levels in children and adolescents with attention deficit hyperactivity disorder","volume":"115","author":"Aydin","year":"2019","journal-title":"J Psychiatr Res"},{"key":"R4-20230927","first-page":"191","article-title":"Diagnostic and statistical manual of mental disorders (DSM)","volume":"25","author":"Battle","year":"2013","journal-title":"Codas"},{"key":"R5-20230927","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.biopsych.2004.10.020","article-title":"Attention-deficit\/hyperactivity disorder:a selective overview","volume":"57","author":"Biederman","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R6-20230927","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.psychres.2019.02.037","article-title":"Changes in serum miRNA-let-7 level in children with attention deficit hyperactivity disorder treated by repetitive transcranial magnetic stimulation or atomoxetine:an exploratory trial","volume":"274","author":"Cao","year":"2019","journal-title":"Psychiatry Res"},{"key":"R7-20230927","doi-asserted-by":"crossref","first-page":"e1148","DOI":"10.4088\/JCP.12040vr1c","article-title":"Diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder","volume":"76","author":"Colvin","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"R8-20230927","doi-asserted-by":"crossref","first-page":"131","DOI":"10.5483\/BMBRep.2009.42.3.131","article-title":"The role of microRNAs in synaptic development","volume":"42","author":"Corbin","year":"2009","journal-title":"BMB Rep"},{"key":"R9-20230927","doi-asserted-by":"crossref","first-page":"262","DOI":"10.9758\/cpn.2021.19.2.262","article-title":"miR-132 and miR-942 expression levels in children with attention deficit and hyperactivity disorder:a controlled study","volume":"19","author":"Coskun","year":"2021","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"R11-20230927","doi-asserted-by":"crossref","first-page":"963689720947416","DOI":"10.1177\/0963689720947416","article-title":"The association between Parkinson's disease and attention-deficit hyperactivity disorder","volume":"29","author":"Fan","year":"2020","journal-title":"Cell Transplant"},{"key":"R12-20230927","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","article-title":"Molecular genetics of attention-deficit\/hyperactivity disorder","volume":"57","author":"Faraone","year":"2005","journal-title":"Biol Psychiatry"},{"key":"R13-20230927","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11920-014-0497-1","article-title":"Biomarkers in the diagnosis of ADHD--promising directions","volume":"16","author":"Faraone","year":"2014","journal-title":"Curr Psychiatry Rep"},{"key":"R15-20230927","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2215-0366(16)00096-1","article-title":"Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms","volume":"3","author":"Gallo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"R16-20230927","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/mp.2017.242","article-title":"Why is there selective subcortical vulnerability in ADHD?Clues from postmortem brain gene expression data","volume":"23","author":"Hess","year":"2018","journal-title":"Mol Psychiatry"},{"key":"R17-20230927","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7150\/ijms.4892","article-title":"Increased locomotor activity and non-selective attention and impaired learning ability in SD rats after lentiviral vector-mediated RNA interference of Homer 1a in the brain","volume":"10","author":"Hong","year":"2013","journal-title":"Int J Med Sci"},{"key":"R18-20230927","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/emj.20.5.453","article-title":"An introduction to power and sample size estimation","volume":"20","author":"Jones","year":"2003","journal-title":"Emerg Med J"},{"key":"R19-20230927","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1007\/s12031-021-01825-7","article-title":"The potential role of miRNAs as predictive biomarkers in neurodevelopmental disorders","volume":"71","author":"Juvale","year":"2021","journal-title":"J Mol Neurosci"},{"key":"R20-20230927","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2014.07.060","article-title":"Evaluation of several micro RNA (miRNA) levels in children and adolescents with attention deficit hyperactivity disorder","volume":"580","author":"Kandemir","year":"2014","journal-title":"Neurosci Lett"},{"key":"R21-20230927","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.psychres.2018.12.175","article-title":"Chronotypical characteristics and related miR-142-3p levels of children with attention deficit and hyperactivity disorder","volume":"273","author":"Karadag","year":"2019","journal-title":"Psychiatry Res"},{"key":"R22-20230927","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa1806828","article-title":"Attention deficit-hyperactivity disorder and month of school enrollment","volume":"379","author":"Layton","year":"2018","journal-title":"N Eng J Med"},{"key":"R24-20230927","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/brainsci9100288","article-title":"Integrated analysis of microRNA and mRNA expression profiles:an attempt to disentangle the complex interaction network in attention deficit hyperactivity disorder","volume":"9","author":"Nuzziello","year":"2019","journal-title":"Brain Sci"},{"key":"R25-20230927","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s11064-019-02917-y","article-title":"MicroRNAs and child neuropsychiatric disorders:a brief review","volume":"45","author":"Paul","year":"2020","journal-title":"Neurochem Res"},{"key":"R26-20230927","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3389\/fnins.2014.00389","article-title":"Impulsivity and comorbid traits:a multi-step approach for finding putative responsible microRNAs in the amygdala","volume":"8","author":"Pietrzykowski","year":"2014","journal-title":"Front Neurosci"},{"key":"R27-20230927","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades:an updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"Int J Epidemiol"},{"key":"R28-20230927","first-page":"315","article-title":"Treatment guidelines for attention deficit and hyperactivity disorder:a critical review","volume":"42","author":"Rabito-Akon","year":"2014","journal-title":"Actas Esp Psiquiatr"},{"key":"R29-20230927","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/etm.2020.9499","article-title":"miR-126-5p regulates H9c2 cell proliferation and apoptosis under hypoxic conditions by targeting IL-17A","volume":"21","author":"Ren","year":"2021","journal-title":"Exp Ther Med"},{"key":"R30-20230927","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1087054712473835","article-title":"Toward quality care in ADHD:defining the goals of treatment","volume":"19","author":"Rostain","year":"2015","journal-title":"J Atten Disord"},{"key":"R31-20230927","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/s41386-018-0297-0","article-title":"Epigenetic signature for attention-deficit\/hyperactivity disorder:identification of miR-26b-5p, miR-185-5p, and miR-191-5p as potential biomarkers in peripheral blood mononuclear cells","volume":"44","author":"S\u00e1nchez-Mora","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"R32-20230927","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"R33-20230927","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12402-017-0232-y","article-title":"Emerging role of miRNA in attention deficit hyperactivity disorder:a systematic review","volume":"10","author":"Srivastav","year":"2018","journal-title":"Atten Defic Hyperact Disord"},{"key":"R34-20230927","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1089\/cap.2019.0043","article-title":"New formulations of stimulants:an update for clinicians","volume":"29","author":"Steingard","year":"2019","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"R35-20230927","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3390\/cells7120245","article-title":"Exploring microRNA biomarkers for Parkinson's disease from mRNA expression profiles","volume":"7","author":"Taguchi","year":"2018a","journal-title":"Cells"},{"key":"R36-20230927","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/ijms19051318","article-title":"Exploring microRNA biomarker for amyotrophic lateral sclerosis","volume":"19","author":"Taguchi","year":"2018b","journal-title":"Int J Mol Sci"},{"key":"R37-20230927","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jpsychires.2021.03.012","article-title":"Peripheral biomarkers of attention-deficit hyperactivity disorder:current status and future perspective","volume":"137","author":"Takahashi","year":"2021","journal-title":"J Psychiatr Res"},{"key":"R38-20230927","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cch.12139","article-title":"Attention-deficit hyperactivity disorder (ADHD):an updated review of the essential facts","volume":"40","author":"Tarver","year":"2014","journal-title":"Child Care Health Dev"},{"key":"R39-20230927","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/cells9040841","article-title":"The promise and challenges of developing miRNA-based therapeutics for Parkinson's disease","volume":"9","author":"Titze-de-Almeida","year":"2020","journal-title":"Cells"},{"key":"R40-20230927","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fpsyt.2018.00227","article-title":"Blood-bourne microRNA biomarker evaluation in attention-deficit\/hyperactivity disorder of Han Chinese individuals:an exploratory study","volume":"9","author":"Wang","year":"2018","journal-title":"Front Psychiatry"},{"key":"R41-20230927","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00406-019-01032-x","article-title":"Gray matter volume and microRNA levels in patients with attention-deficit\/hyperactivity disorder","volume":"270","author":"Wang","year":"2020","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R42-20230927","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41398-022-01832-1","article-title":"MicroRNAs serve as prediction and treatment-response biomarkers of attention-deficit\/hyperactivity disorder and promote the differentiation of neuronal cells by repressing the apoptosis pathway","volume":"12","author":"Wang","year":"2022","journal-title":"Transl Psychiatry"},{"key":"R43-20230927","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pscychresns.2012.01.005","article-title":"White matter abnormalities associated with disruptive behavior disorder in adolescents with and without attention-deficit\/hyperactivity disorder","volume":"202","author":"Wang","year":"2012","journal-title":"Psychiatry Res"},{"key":"R44-20230927","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnmol.2016.00129","article-title":"Getting miRNA therapeutics into the target cells for neurodegenerative diseases:a mini-review","volume":"9","author":"Wen","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"R45-20230927","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1750-3639.2010.00410.x","article-title":"A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain","volume":"20","author":"Wu","year":"2010","journal-title":"Brain Pathol"},{"key":"R46-20230927","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12017-015-8345-y","article-title":"Circulating microRNA let-7d in attention-deficit\/hyperactivity disorder","volume":"17","author":"Wu","year":"2015","journal-title":"Neuromolecular Med"},{"key":"R47-20230927","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s12035-015-9679-z","article-title":"Nr3C1-Bhlhb2 axis dysregulation is involved in the development of attention deficit hyperactivity","volume":"54","author":"Wu","year":"2017","journal-title":"Mol Neurobiol"},{"key":"R48-20230927","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3389\/fneur.2019.01414","article-title":"Effects of aberrant miR-384-5p expression on learning and memory in a rat model of attention deficit hyperactivity disorder","volume":"10","author":"Xu","year":"2020","journal-title":"Front Neurol"},{"key":"R49-20230927","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.brainres.2013.03.030","article-title":"The role of Homer 1a in increasing locomotor activity and non-selective attention, and impairing learning and memory abilities","volume":"1515","author":"Yang","year":"2013","journal-title":"Brain Res"},{"key":"R50-20230927","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1007\/s10753-020-01257-2","article-title":"KCNQ1OT1 Exacerbates ischemia-reperfusion injury through targeted inhibition of miR-140-3P","volume":"43","author":"Yi","year":"2020","journal-title":"Inflammation"},{"key":"R51-20230927","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jpsychires.2018.12.013","article-title":"Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations","volume":"109","author":"Zadehbagheri","year":"2019","journal-title":"J Psychiatr Res"},{"key":"R52-20230927","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mpr.7","article-title":"ADHD Rating Scale IV:psychometric properties from a multinational study as a clinician-administered instrument","volume":"14","author":"Zhang","year":"2005","journal-title":"Int J Methods Psychiatr Res"},{"key":"R53-20230927","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/1354750X.2021.2024600","article-title":"MicroRNA profile as potential molecular signature for attention deficit hyperactivity disorder in children","volume":"27","author":"Zhu","year":"2022","journal-title":"Biomarkers"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.380880","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:13:10Z","timestamp":1787166790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.380880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/1673-5374.380880","relation":{},"ISSN":["1673-5374","1876-7958"],"issn-type":[{"value":"1673-5374","type":"print"},{"value":"1876-7958","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]}}}